Search Prime Grants

HT94252510909

Project Grant

Overview

Grant Description
Globals - Global omic biomarker research for ALS
Awardee
Weizmann Institute Of Science
Funding Goals
AMYOTROPHIC LATERAL SCLEROSIS RESEARCH PROGRAM AWARD MECHANISM: CLINICAL OUTCOMES AND BIOMARKERS AWARD
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Israel
Geographic Scope
Foreign
Related Opportunity
DOD Amyotrophic Lateral Sclerosis, Clinical Outcomes and Biomarkers Award (HT942524ALSRPCOBA)
Weizmann Institute Of Science was awarded Project Grant HT94252510909 worth $939,325 from Defense Health Agency in November 2025 with work to be completed primarily in Israel. The grant has a duration of 3 years and was awarded through assistance program 12.420 Military Medical Research and Development. The Project Grant was awarded through grant opportunity DOD Amyotrophic Lateral Sclerosis, Clinical Outcomes and Biomarkers Award.

Status
(Ongoing)

Last Modified 9/12/25

Period of Performance
11/1/25
Start Date
10/31/28
End Date
21.0% Complete

Funding Split
$939.3K
Federal Obligation
$0.0
Non-Federal Obligation
$939.3K
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to HT94252510909

Transaction History

Modifications to HT94252510909

Additional Detail

Award ID FAIN
HT94252510909
SAI Number
None
Award ID URI
None
Awardee Classifications
Private Institution Of Higher Education
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
NPJ8YBLFTKX6
Awardee CAGE
2846A
Performance District
Not Applicable
Modified: 9/12/25